Vikram Sudarsan
Amministratore Delegato presso Engrail Therapeutics, Inc.
Posizioni attive di Vikram Sudarsan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Engrail Therapeutics, Inc.
 Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | 01/07/2019 | - |
| Amministratore Delegato | 01/07/2019 | - | |
| Presidente | 01/07/2019 | - |
Storia della carriera di Vikram Sudarsan
Precedenti posizioni note di Vikram Sudarsan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Chase Pharmaceuticals Corp.
 Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC. | Direttore/Membro del Consiglio | 12/05/2014 | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| President | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Chase Pharmaceuticals Corp.
Chase Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Chase Pharmaceuticals Corp. develops novel medications for the treatment of Alzheimer’s disease. It focuses on pharmaceuticals for Alzheimer type dementia, which include oral medications such as its lead product, CPC-201, as well as CPC 252 for transdermal administration. The company was founded by Thomas N. Chase and Kathleen Clarence-Smith in 2007 and is headquartered in Washington, DC. | Health Technology |
Engrail Therapeutics, Inc.
Engrail Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Vikram Sudarsan
- Esperienza
